Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis.

@article{Antoniou2007PathogeneticPA,
  title={Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis.},
  author={Katerina M. Antoniou and Athanasia D Pataka and Demosthenes Bouros and Nikolaos Siafakas},
  journal={Pulmonary pharmacology & therapeutics},
  year={2007},
  volume={20 5},
  pages={453-61}
}
Idiopathic pulmonary fibrosis (IPF) is a poorly understood disease that usually leads to death within 5 years of diagnosis. Despite our better understanding of IPF pathogenesis, the etiology and the precise cellular and molecular mechanisms involved are not well known. Current therapies are of unproven benefit. The aim of this review is to identify possible… CONTINUE READING